Biotechnology
RNA medicines: what technologies are investors funding?
RNA medicine has spawned many new technologies and approaches. Examine market trends and where investors are funneling their money.
Read the CAS Insights article
Bio
Prior to joining CAS, Gilles held various executive positions including as Vice President and General Manager at Milacron; Business Director at DuPont/Axalta; and as the Global Business Development Manager at 3M, as well as multiple other roles across R&D, business and sales functions in the aerospace, oil & gas, industrial, optical and electronics industries. Gilles holds a Ph.D. in chemistry from the University of Montreal, Canada, an MBA from HEC school, Canada, a bachelor’s degrees in chemistry and material sciences from the Université de Pau, France, and is a Six Sigma Black Belt.
Sustainability
Is nuclear energy critical in solving climate change?
Nuclear energy could play a part in solving climate change, but there are still hurdles and challenges that must be overcome.
Read the CAS Insights article